ReviewExploration of targeted anti-tumor therapy2024

Blood-based circulating biomarkers for prediction of immune-checkpoint inhibitors efficacy in renal cell carcinoma.

Loubna Omri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.